http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009155331-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_014116c1149172341d3d5f11a71c8c5a |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-16 |
filingDate | 2008-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73709a0fe65f6de34f85053f0ef724a9 |
publicationDate | 2009-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2009155331-A |
titleOfInvention | Anti-fatigue |
abstract | PROBLEM TO BE SOLVED: Fucoxanthin is known to have functions such as diabetes-improving action, angiogenesis-inhibiting action, and DHA synthesis promoting action. The subject of this invention exists in provision of the anti-fatigue agent which uses fucoxanthin and / or fucoxanthinol as an active ingredient which are effective in fatigue reduction other than these. An anti-fatigue agent comprising fucoxanthin and / or fucoxanthinol as an active ingredient. In addition, the fatigue in this invention means the phenomenon in which the function falls as a result of exhibiting a certain function. The anti-fatigue effect referred to in the present invention includes an action of reducing the fatigue state as described above, an action of recovering the fatigue state, an action of preventing the fatigue state, and the like. [Selection figure] None |
priorityDate | 2008-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.